new_0222_0608|SBTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0608|SBTX|1|Silverback Therapeutics Inc Total Current Assets (Quarterly) (USD)|Silverback Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Silverback Therapeutics Inc Inventories (Quarterly) (USD)|Silverback Therapeutics Inc Net PP&E (Quarterly) (USD)|Silverback Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Silverback Therapeutics Inc Total Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Deposits (Quarterly) (USD)|Silverback Therapeutics Inc Book Value (Quarterly) (USD)|Silverback Therapeutics Inc Retained Earnings (Quarterly) (USD)|Silverback Therapeutics Inc Treasury Stock (Quarterly) (USD)|Silverback Therapeutics Inc EV to Revenues|Silverback Therapeutics Inc EV to Earnings|Silverback Therapeutics Inc EV to Free Cash Flow|Silverback Therapeutics Inc EV to Assets (Quarterly)|Silverback Therapeutics Inc PS Ratio|Silverback Therapeutics Inc PE Ratio|Silverback Therapeutics Inc Price to Book Value|Silverback Therapeutics Inc PEG Ratio|Silverback Therapeutics Inc Debt to Equity Ratio|Silverback Therapeutics Inc Dividend Yield|Silverback Therapeutics Inc Shareholder Yield (TTM)|Silverback Therapeutics Inc Percent of Shares Outstanding Short|Silverback Therapeutics Inc Total Receivables (Quarterly) (USD)|Silverback Therapeutics Inc Total Payables (Quarterly) (USD)|Silverback Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Silverback Therapeutics Inc Return on Invested Capital|Silverback Therapeutics Inc Quality Ratio Score|Silverback Therapeutics Inc Momentum Score|Silverback Therapeutics Inc Beta (1Y)|Silverback Therapeutics Inc Sustainable Growth Rate (TTM)|Silverback Therapeutics Inc Institutional Investor Ownership Percentage|Silverback Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Silverback Therapeutics Inc Total Employees (Annual)|Silverback Therapeutics Inc EPS Diluted (Quarterly) (USD)|Silverback Therapeutics Inc SG&A Expense (Quarterly) (USD)|Silverback Therapeutics Inc Shares Outstanding|Silverback Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Silverback Therapeutics Inc Ordinary Shares Number (Quarterly)|Silverback Therapeutics Inc Payout Ratio|Silverback Therapeutics Inc Quick Ratio (Quarterly)|Silverback Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Silverback Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Silverback Therapeutics Inc Effective Tax Rate (TTM)|Silverback Therapeutics Inc Return on Equity|Silverback Therapeutics Inc Net Income (TTM) (USD)|Silverback Therapeutics Inc Revenue (TTM) (USD)|Silverback Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Silverback Therapeutics Inc Revenue (Quarterly) (USD)|Silverback Therapeutics Inc Gross Profit (Quarterly) (USD)|Silverback Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Silverback Therapeutics Inc Net Income (Quarterly) (USD)|Silverback Therapeutics Inc Net Interest Income (Quarterly) (USD)|Silverback Therapeutics Inc Price (USD)|Silverback Therapeutics Inc Total Return Price (USD)|Silverback Therapeutics Inc Enterprise Value (USD)|Silverback Therapeutics Inc 30-Day Average Daily Volume|Silverback Therapeutics Inc 1 Year Price Returns (Daily)|Silverback Therapeutics Inc Short Interest|Silverback Therapeutics Inc PE Ratio (Forward)|Silverback Therapeutics Inc PE Ratio (Forward 1y)|Silverback Therapeutics Inc PS Ratio (Forward)|Silverback Therapeutics Inc PS Ratio (Forward 1y)|Silverback Therapeutics Inc Quarterly EPS Estimates (USD)|Silverback Therapeutics Inc Quarterly Revenue Estimates (USD)|Silverback Therapeutics Inc Quarterly EPS Surprise|Silverback Therapeutics Inc Quarterly Revenue Surprise|Silverback Therapeutics Inc Quarterly Actual EPS (USD)|Silverback Therapeutics Inc Quarterly Actual Revenue (USD)|Silverback Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Silverback Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Silverback Therapeutics Inc Price Target (USD)|Silverback Therapeutics Inc Consensus Recommendation|Silverback Therapeutics Inc Price Target Num Estimates|Silverback Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Silverback Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Silverback Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Silverback Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Silverback Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Silverback Therapeutics Inc Land and Improvements (Quarterly) (USD)|Silverback Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Silverback Therapeutics Inc Other Properties (Quarterly) (USD)|Silverback Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0608|SBTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0608|SBTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0608|SBTX|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||1.44755244755||||1.44755244755|||1.45065789474||15.2592592593||127.8|127.8||||31|||91.2857142857|121.666666667|91.2857142857|91.2857142857|28.5833333333||127.8|||91.2857142857||||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.45065789474|1.45065789474|1.45065789474|1.43636363636|1.42307692308|15.2592592593|||||91.3|91.25|91||91|91|106|35.3333333333|22.7142857143|16.7368421053|22.7142857143|52.8333333333|52.8333333333|91.2857142857|91.2857142857||||127.8|183||
new_0222_0608|SBTX|6|5|5||5||5|5|5||5|5||||286||||286|||304||27||5|5||||1|||7|3|7|7|12||5|||7||||4|||||7|7|7|304|304|304|275|52|27|||||10|8|3||3|3|3|9|14|19|14|6|6|7|7||||5|2||
new_0222_0608|SBTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0608|SBTX|201912|10.528|9.976||4.569||74.424|17.926|56.498||-58.777|-63.787|||||||||||||||3.518||||||||9.2554||-0.7531|0.658|||28.5167|||-0.7531|||||||||-6.97|-6.97|-0.039||||||||||||||||||||||||6.273|0.138||||5.863|0.156||
new_0222_0608|SBTX|202003||||||||||||||||||||||||||||||||||9.2554||-0.5704|0.828||||||-0.5704|||||||||-5.279|-5.279|-0.037|||||||||||-0.18|||||||||||||4.414|0.139|||||||
new_0222_0608|SBTX|202006||||||||||||||||||||||||||||||||||9.2554||-0.6987|1.337||||||-0.6987|||||||||-6.467|-6.467|-0.004|||||||||||-0.28|||||||||||||5.126|0.138|||||||
new_0222_0608|SBTX|202009|143.182|142.317||4.159||227.16|8.005|219.155||-78.249|-83.649|||||||||||||||2.157||||||||28.5167|52|-0.2846|1.912|28.5167||28.5167|||-0.2846||||-26.832|||||-8.116|-8.116|-0.004|||||||||||-0.46|||||||||||||6.2|0.171||||4.159|||
new_0222_0608|SBTX|202012|390.656|386.569||3.798||11.927|9.601|2.326||382.877|-96.734||||-38.0635||||4.1999|||||1.9849||2.583|0.003|||||||34.7013|54|-1.37|4.264|34.7013||34.7013|||-1.37||||-32.947|||||-13.085|-13.085|0.016|46.34|46.34|1222.3332|178883.3||688800|||||-0.405||7.163||-0.376||||46.25|1.5|4|-1.185|-1.83|8.837|0.189||||5.581|0.269|43.92|48.06
new_0222_0608|SBTX|202103|378.346|374.205||3.503||13.65|11.595|2.055||368.549|-115.601||||-31.2309||||4.123|||||8.6424||4.374|0.003|||||||34.7739||-0.54|6.646|34.8272||34.8272|||-0.54||||-46.535|||||-18.867|-18.867|0.018|43.63|43.63|1145.8007|307328.6667||3009918|||||-0.39||-38.4615||-0.54||||50|1.5|4|-1.875|-2.71|12.239|0.186||||3.503||32.05|27.53
new_0222_0608|SBTX|202106|363.027|359.689||3.599||17.326|15.548|1.778||349.65|-140.097||||-15.6337||||3.0888|||||9.1346||1.805|0.004|||||||34.876|76|-0.7|6.762|34.9631||34.9631|||-0.7||||-64.564|||||-24.496|-24.496|0.015|30.89|30.89|720.3212|129388.3667||3193742|||||-0.5633||-24.2611||-0.7||||49.5|1.5|4|-2.6767|-3.7067|17.749|0.207||||3.599||30.28|22
new_0222_0608|SBTX|202109|305.355|300.66||6.918||20.427|15.347|5.08||332.134|-162.752||||-0.8506||||1.0528|||||11.4893||1.72|0.004|||||||35.0015|83|-0.65|7.04|35.0371||35.0371|||-0.65||||-79.103|||||-22.655|-22.655|0.026|9.98|9.98|49.0103|589091.1333||4025539|||||-0.7||||-0.7||||44.25|1.5|4|-2.6767|-3.7067|15.641|0.203||||6.918||8.63|7.03
new_0222_0608|SBTX|202112|||||||||||||||1.1637||||0.7034|||||4.4791||||||1|2.367||||||||||||||||||||||||6.66|6.66|-67.0532|453870.3|-85.628|1573668|||||-0.6333||||||||||||||||||||4.87|3.88
new_0222_0608|SBTX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.66|||||||||||||||||||||
new_0222_0608|SBTX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.86|||||||||||||||||||||
new_0222_0608|SBTX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.79|||||||||||||||||||||
new_0222_0608|SBTX|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||